TY - JOUR
T1 - Lymphomas and lymphoproliferative disorders clinically presenting as renal carcinoma
T2 - A clinicopathological study of 14 cases
AU - Chen, Longwen
AU - Richendollar, Bill
AU - Bunting, Sylvia
AU - Campbell, Steve
AU - Zhou, Ming
PY - 2013/12
Y1 - 2013/12
N2 - Aims: Although uncommon, lymphomas and lympho-proliferative disorders (LPDs) that manifest as renal or peri-renal masses can mimic primary renal cancers upon clinical and radiological evaluations. However, such distinction is critical as the management of these diseases are drastically different. This study reports the clinical, radiological and pathological features of 14 lymphomas/LPDs that were initially managed as primary renal carcinomas. Methods: The surgical pathology file was queried for kidney resections or biopsies with a diagnosis of lymphoma or LPD. The clinical symptomatology, imaging results, pathology data, treatment regimens and outcome data were obtained by electronic patient data search and/or chart review. Results: Lymphomas/LPDs accounted for only 29 of 5490 (0.5%) of renal neoplasms diagnosed by pathology over a 27 year period. Of these 29 cases, 14 had a presumptive clinical diagnosis of renal carcinoma prior to nephrectomy or biopsy. Eleven of 14 (78.6%) had concurrent retroperitoneal, periaortic or distant adenopathy. Only two cases had inferior vena caval invasion. On pathological examination, the majority of these cases were mature B-cell neoplasms; however, three of 14 cases were initially interpreted as poorly differentiated carcinoma on routine histological sections. Upon staging, all 14 cases had nodal and/or additional extranodal involvement while only two of 14 cases demonstrated vascular invasion. Conclusions: Lymphomas/LPDs should always be kept in the differential diagnosis for unusual renal or perirenal masses. Extensive regional or distant adenopathy without vascular invasion favours a clinical diagnosis of LPD, while the presence of both regional adenopathy and vascular invasion should raise clinical suspicion for renal carcinoma.
AB - Aims: Although uncommon, lymphomas and lympho-proliferative disorders (LPDs) that manifest as renal or peri-renal masses can mimic primary renal cancers upon clinical and radiological evaluations. However, such distinction is critical as the management of these diseases are drastically different. This study reports the clinical, radiological and pathological features of 14 lymphomas/LPDs that were initially managed as primary renal carcinomas. Methods: The surgical pathology file was queried for kidney resections or biopsies with a diagnosis of lymphoma or LPD. The clinical symptomatology, imaging results, pathology data, treatment regimens and outcome data were obtained by electronic patient data search and/or chart review. Results: Lymphomas/LPDs accounted for only 29 of 5490 (0.5%) of renal neoplasms diagnosed by pathology over a 27 year period. Of these 29 cases, 14 had a presumptive clinical diagnosis of renal carcinoma prior to nephrectomy or biopsy. Eleven of 14 (78.6%) had concurrent retroperitoneal, periaortic or distant adenopathy. Only two cases had inferior vena caval invasion. On pathological examination, the majority of these cases were mature B-cell neoplasms; however, three of 14 cases were initially interpreted as poorly differentiated carcinoma on routine histological sections. Upon staging, all 14 cases had nodal and/or additional extranodal involvement while only two of 14 cases demonstrated vascular invasion. Conclusions: Lymphomas/LPDs should always be kept in the differential diagnosis for unusual renal or perirenal masses. Extensive regional or distant adenopathy without vascular invasion favours a clinical diagnosis of LPD, while the presence of both regional adenopathy and vascular invasion should raise clinical suspicion for renal carcinoma.
KW - Kidney
KW - Lymphoma
KW - Lymphoproliferative disorder
KW - Renal cell carcinoma
KW - Urothelial carcinoma
UR - http://www.scopus.com/inward/record.url?scp=84896785599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896785599&partnerID=8YFLogxK
U2 - 10.1097/PAT.0000000000000006
DO - 10.1097/PAT.0000000000000006
M3 - Article
C2 - 24247623
AN - SCOPUS:84896785599
SN - 0031-3025
VL - 45
SP - 657
EP - 663
JO - Pathology
JF - Pathology
IS - 7
ER -